В. Д. Ермилова

1.0k total citations
35 papers, 681 citations indexed

About

В. Д. Ермилова is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, В. Д. Ермилова has authored 35 papers receiving a total of 681 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 16 papers in Cancer Research and 10 papers in Oncology. Recurrent topics in В. Д. Ермилова's work include Epigenetics and DNA Methylation (11 papers), MicroRNA in disease regulation (7 papers) and Skin and Cellular Biology Research (5 papers). В. Д. Ермилова is often cited by papers focused on Epigenetics and DNA Methylation (11 papers), MicroRNA in disease regulation (7 papers) and Skin and Cellular Biology Research (5 papers). В. Д. Ермилова collaborates with scholars based in Russia, United States and Sweden. В. Д. Ермилова's co-authors include V. I. Guelstein, Э. А. Брага, В. И. Логинов, T. P. Kazubskaya, Sergey M. Troyanovsky, Р Ф Гарькавцева, G. A. Bannikov, Eugene R. Zabarovsky, Lev L. Kisselev and Alexander V. Ljubimov and has published in prestigious journals such as SHILAP Revista de lepidopterología, Oncogene and FEBS Letters.

In The Last Decade

В. Д. Ермилова

34 papers receiving 666 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
В. Д. Ермилова Russia 14 477 223 155 118 68 35 681
Silvia Giampieri United Kingdom 6 374 0.8× 153 0.7× 388 2.5× 163 1.4× 55 0.8× 9 737
Cornelia Kröger United States 8 454 1.0× 161 0.7× 309 2.0× 347 2.9× 44 0.6× 8 843
Gabi Stumm Germany 7 290 0.6× 143 0.6× 178 1.1× 97 0.8× 62 0.9× 14 601
Chengxin Li China 13 592 1.2× 95 0.4× 257 1.7× 59 0.5× 62 0.9× 19 814
Anne‐Aurélie Raymond France 14 339 0.7× 101 0.5× 99 0.6× 182 1.5× 42 0.6× 32 640
P S Rudland United Kingdom 12 395 0.8× 114 0.5× 314 2.0× 92 0.8× 43 0.6× 20 730
Kirsten Smalley United States 11 624 1.3× 158 0.7× 404 2.6× 85 0.7× 95 1.4× 16 907
Donatello Castellana Spain 9 521 1.1× 329 1.5× 144 0.9× 88 0.7× 31 0.5× 9 816
Meenhard Herlyn United States 9 413 0.9× 119 0.5× 313 2.0× 124 1.1× 43 0.6× 9 727
Gabriele Prescher Germany 12 535 1.1× 197 0.9× 531 3.4× 158 1.3× 97 1.4× 16 1.3k

Countries citing papers authored by В. Д. Ермилова

Since Specialization
Citations

This map shows the geographic impact of В. Д. Ермилова's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by В. Д. Ермилова with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites В. Д. Ермилова more than expected).

Fields of papers citing papers by В. Д. Ермилова

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by В. Д. Ермилова. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by В. Д. Ермилова. The network helps show where В. Д. Ермилова may publish in the future.

Co-authorship network of co-authors of В. Д. Ермилова

This figure shows the co-authorship network connecting the top 25 collaborators of В. Д. Ермилова. A scholar is included among the top collaborators of В. Д. Ермилова based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with В. Д. Ермилова. В. Д. Ермилова is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Герштейн, Е. С., et al.. (2022). Soluble forms of PD-1/PD-L immune checkpoint receptor and ligand in blood serum of breast cancer patients: association with clinical pathologic factors and molecular type of the tumor. Russian Clinical Laboratory Diagnostics. 67(2). 76–80. 2 indexed citations
2.
Логинов, В. И., A. M. Burdennyy, Е. А. Филиппова, et al.. (2018). Гиперметилирование генов микроРНК miR-107, miR-130b, miR-203a, miR-1258 ассоциировано с развитием и метастазированием рака яичников. Молекулярная биология. 52(5). 801–809. 9 indexed citations
3.
Брага, Э. А., В. И. Логинов, Е. А. Филиппова, et al.. (2018). Five Hypermethylated MicroRNA Genes as Potential Markers of Ovarian Cancer. Bulletin of Experimental Biology and Medicine. 164(3). 351–355. 25 indexed citations
4.
Герштейн, Е. С., et al.. (2018). Matrix Metalloproteinases and Their Tissue Inhibitors in Blood Serum of Patients with Endometrial Cancer: Clinical and Morphological Correlations. Bulletin of Experimental Biology and Medicine. 165(1). 75–79. 7 indexed citations
5.
Пронина, И. В., Е.А. Климов, A. M. Burdennyy, et al.. (2017). Methylation of the genes for the microRNAs miR-129-2 and miR-9-1, changes in their expression, and activation of their potential target genes in clear cell renal cell carcinoma. Molecular Biology. 51(1). 61–71. 6 indexed citations
6.
Scherbakov, Alexander M., et al.. (2016). Regulatory Proteins of Epithelial-Mesenchymal Transition and Some Components of VEGF Signaling Pathway in Breast Cancer. Bulletin of Experimental Biology and Medicine. 160(6). 802–806. 3 indexed citations
7.
Ермилова, В. Д., et al.. (2016). Analysis of the results of treatment of patients with malignant tumors of the salivary glands. Head and neck tumors (HNT). 6(3). 42–52. 2 indexed citations
8.
Lallemand, François, Sophie Vacher, Nicolas Molinié, et al.. (2016). Arpin downregulation in breast cancer is associated with poor prognosis. British Journal of Cancer. 114(5). 545–553. 25 indexed citations
9.
Sajet, Anita, Gerrit‐Jan Liefers, Esther Bastiaannet, et al.. (2012). Прогностическое значение возраста больных при раннем раке молочной железы. 1 indexed citations
10.
Герштейн, Е. С., et al.. (2011). Matrix Metalloproteinases 2, 7, and 9 in Tumors and Sera of Patients with Breast Cancer. Bulletin of Experimental Biology and Medicine. 151(3). 359–362. 18 indexed citations
11.
Ермилова, В. Д., et al.. (2010). Клинико-морфологические особенности и прогноз при редких формах рака молочной железы.
12.
Завалишина, Л Э, et al.. (2010). Cellular Expression of INK4a Gene in Cells of Bladder Cancer Associated with Human Papilloma Virus-16. Bulletin of Experimental Biology and Medicine. 149(2). 242–245. 2 indexed citations
13.
Сенченко, В. Н., Jian Liu, В. И. Логинов, et al.. (2004). Discovery of frequent homozygous deletions in chromosome 3p21.3 LUCA and AP20 regions in renal, lung and breast carcinomas. Oncogene. 23(34). 5719–5728. 95 indexed citations
14.
Кушлинский, Н. Е., et al.. (2004). Expression of Biomolecular Markers (Ki-67, PCNA, Bcl-2, BAX, BclX, VEGF) in Breast Tumors. Bulletin of Experimental Biology and Medicine. 137(2). 182–185. 23 indexed citations
15.
Брага, Э. А., Elena M. Pugacheva, Igor Bazov, et al.. (1999). Comparative allelotyping epithelial tumors of the short arm of human chromosome 3 in of four different types. FEBS Letters. 454(3). 215–219. 34 indexed citations
16.
Ермилова, В. Д., et al.. (1997). Breast Tumor Diagnosis in Cytologic Aspirates Using Monoclonal Antibodies to Keratin 8 and 17. Acta Cytologica. 41(2). 307–312. 3 indexed citations
17.
Baibakov, Boris, et al.. (1994). Organotypic growth and differentiation of human mammary gland in sponge-gel matrix supported histoculture. In Vitro Cellular & Developmental Biology - Animal. 30(8). 490–495. 3 indexed citations
18.
Guelstein, V. I., et al.. (1993). Myoepithelial and basement membrane antigens in benign and malignant human breast tumors. International Journal of Cancer. 53(2). 269–277. 61 indexed citations
19.
Guelstein, V. I., et al.. (1993). Immunohistochemical localization of cytokeratin 17 in transitional cell carcinomas of the human urinary tract. Virchows Archiv B Cell Pathology Including Molecular Pathology. 64(1). 1–5. 14 indexed citations
20.
Guelstein, V. I., et al.. (1988). Monoclonal antibody mapping of keratins 8 and 17 and of vimentin in normal human mammary gland, benign tumors, dysplasias and breast cancer. International Journal of Cancer. 42(2). 147–153. 127 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silvia Giampieri Breakdown of academic impact, for papers by Cornelia Kröger Breakdown of academic impact, for papers by Gabi Stumm Breakdown of academic impact, for papers by Chengxin Li Breakdown of academic impact, for papers by Anne‐Aurélie Raymond Breakdown of academic impact, for papers by P S Rudland Breakdown of academic impact, for papers by Kirsten Smalley Breakdown of academic impact, for papers by Donatello Castellana Breakdown of academic impact, for papers by Meenhard Herlyn Breakdown of academic impact, for papers by Gabriele Prescher
Rankless by CCL
2026